Alnylam’s discontinued late-stage drug put a buzzed-about drug technology in its crosshairs By: MarketWatch October 06, 2016 at 14:06 PM EDT And Wall Street is scattered all over the place. Read More >> Related Stocks: Alnylam Pharmaceuticals Arbutus Biopharma Corp Arrowhead Pharma Standard & Poors 500